Search results
Results from the WOW.Com Content Network
The synthetic cannabinoids that have emerged recently have even greater structural diversity, possibly to subvert legal regulations on earlier generations of synthetic cannabinoids. There are a few different structural classifications of synthetic cannabinoids that include many of the new structures, some of which are shown in table one.
JWH-018, a potent synthetic cannabinoid agonist discovered by John W. Huffman at Clemson University. It was often sold in legal smoke blends collectively known as "spice". Several countries and states have moved to ban it legally. JWH-073; CP-55940, produced in 1974, this synthetic cannabinoid receptor agonist is many times more potent than THC.
Notes: · Reflects laws of states and territories, including laws which have not yet gone into effect. Does not reflect federal, tribal, or local laws. · Map does not show state legality of hemp-derived cannabinoids such as CBD or delta-8-THC, which have been legal at federal level since enactment of the 2018 Farm Bill
Vitamin K2 is lauded for a number of important health benefits. But taking too much can be dangerous, health experts say.
Vitamin K 2, the main storage form in animals, has several subtypes, which differ in isoprenoid chain length. These vitamin K 2 homologues are called menaquinones, and are characterized by the number of isoprenoid residues in their side chains.
Search the web. Legal Main; Terms of Service Summary; Terms of Service; Legal Information Privacy Policy. Privacy Policy Highlights
K2 Asset Management Holdings Ltd (ASX:KAM) is currently trading at a trailing P/E of 8x, which is lower than the industry average of 18.9x. Although some investors may jump toRead More...
On October 18, 1985, the DEA issued a Notice of Proposed Rulemaking to transfer "Synthetic Dronabinol in Sesame Oil and Encapsulated in Soft Gelatin Capsules" — a pill form of Δ 9-tetrahydrocannabinol, the main psychoactive component of cannabis, sold under the brand name Marinol — from Schedule I to Schedule II (DEA 50 FR 42186-87).